Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.
Curr Pharm Des. 2009;15(35):4017-25. doi: 10.2174/138161209789824768.
G Protein-Coupled Receptors (GPCRs) are the most targeted group of proteins for the development of therapeutic drugs. Until the last decade, structural information about this family of membrane proteins was relatively scarce, and their mechanisms of ligand binding and signal transduction were modeled on the assumption that GPCRs existed and functioned as monomeric entities. New crystal structures of native and engineered GPCRs, together with important biochemical and biophysical data that reveal structural details of the activation mechanism(s) of this receptor family, provide a valuable framework to improve dynamic molecular models of GPCRs with the ultimate goal of elucidating their allostery and functional selectivity. Since the dynamic movements of single GPCR protomers are likely to be affected by the presence of neighboring interacting subunits, oligomeric arrangements should be taken into account to improve the predictive ability of computer-assisted structural models of GPCRs for effective use in drug design.
G 蛋白偶联受体 (GPCRs) 是开发治疗药物的最靶向蛋白群体。直到过去十年,这个膜蛋白家族的结构信息相对较少,它们的配体结合和信号转导机制是基于 GPCR 作为单体存在和发挥作用的假设来建模的。天然和工程化 GPCR 的新晶体结构,以及揭示该受体家族激活机制结构细节的重要生化和生物物理数据,为改进 GPCR 的动态分子模型提供了有价值的框架,最终目标是阐明它们的变构和功能选择性。由于单个 GPCR 原聚体的动态运动可能受到相邻相互作用亚基的存在的影响,因此应该考虑寡聚体排列以提高计算机辅助 GPCR 结构模型的预测能力,以便有效地用于药物设计。